nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—thyroid cancer—head and neck cancer	0.204	0.285	CtDrD
Epirubicin—bone cancer—head and neck cancer	0.151	0.211	CtDrD
Epirubicin—stomach cancer—head and neck cancer	0.143	0.2	CtDrD
Epirubicin—peripheral nervous system neoplasm—head and neck cancer	0.11	0.155	CtDrD
Epirubicin—sarcoma—head and neck cancer	0.106	0.149	CtDrD
Epirubicin—ABCC1—Vinblastine—head and neck cancer	0.0515	0.548	CbGbCtD
Epirubicin—ABCC1—Docetaxel—head and neck cancer	0.0424	0.452	CbGbCtD
Epirubicin—DHCR7—hair follicle—head and neck cancer	0.00187	0.0696	CbGeAlD
Epirubicin—CHD1—parotid gland—head and neck cancer	0.00152	0.0564	CbGeAlD
Epirubicin—CHD1—saliva-secreting gland—head and neck cancer	0.00145	0.054	CbGeAlD
Epirubicin—CHD1—trachea—head and neck cancer	0.00112	0.0417	CbGeAlD
Epirubicin—DHCR7—parotid gland—head and neck cancer	0.00102	0.038	CbGeAlD
Epirubicin—DHCR7—saliva-secreting gland—head and neck cancer	0.00098	0.0364	CbGeAlD
Epirubicin—CHD1—lymphoid tissue—head and neck cancer	0.000977	0.0363	CbGeAlD
Epirubicin—YWHAG—parotid gland—head and neck cancer	0.000939	0.0349	CbGeAlD
Epirubicin—YWHAG—saliva-secreting gland—head and neck cancer	0.000899	0.0334	CbGeAlD
Epirubicin—CHD1—thyroid gland—head and neck cancer	0.000887	0.033	CbGeAlD
Epirubicin—YWHAG—connective tissue—head and neck cancer	0.000826	0.0307	CbGeAlD
Epirubicin—AURKA—lymphoid tissue—head and neck cancer	0.000787	0.0292	CbGeAlD
Epirubicin—CHD1—head—head and neck cancer	0.000787	0.0292	CbGeAlD
Epirubicin—DHCR7—trachea—head and neck cancer	0.000756	0.0281	CbGeAlD
Epirubicin—ABCC1—hair follicle—head and neck cancer	0.000733	0.0272	CbGeAlD
Epirubicin—AURKA—thyroid gland—head and neck cancer	0.000715	0.0266	CbGeAlD
Epirubicin—YWHAG—trachea—head and neck cancer	0.000694	0.0258	CbGeAlD
Epirubicin—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.00069	0.317	CbGdCrCtD
Epirubicin—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.000677	0.311	CbGdCrCtD
Epirubicin—PLA2G4A—saliva-secreting gland—head and neck cancer	0.000671	0.0249	CbGeAlD
Epirubicin—DHCR7—lymphoid tissue—head and neck cancer	0.000659	0.0245	CbGeAlD
Epirubicin—AURKA—head—head and neck cancer	0.000634	0.0236	CbGeAlD
Epirubicin—PLA2G4A—connective tissue—head and neck cancer	0.000616	0.0229	CbGeAlD
Epirubicin—YWHAG—lymphoid tissue—head and neck cancer	0.000604	0.0225	CbGeAlD
Epirubicin—DHCR7—thyroid gland—head and neck cancer	0.000598	0.0222	CbGeAlD
Epirubicin—CHD1—lymph node—head and neck cancer	0.000551	0.0205	CbGeAlD
Epirubicin—YWHAG—thyroid gland—head and neck cancer	0.000549	0.0204	CbGeAlD
Epirubicin—DHCR7—head—head and neck cancer	0.000531	0.0197	CbGeAlD
Epirubicin—PLA2G4A—trachea—head and neck cancer	0.000518	0.0192	CbGeAlD
Epirubicin—YWHAG—head—head and neck cancer	0.000487	0.0181	CbGeAlD
Epirubicin—Daunorubicin—CYP1A1—head and neck cancer	0.000486	1	CrCbGaD
Epirubicin—AURKA—lymph node—head and neck cancer	0.000444	0.0165	CbGeAlD
Epirubicin—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.000435	0.2	CbGdCrCtD
Epirubicin—PLA2G4A—thyroid gland—head and neck cancer	0.000409	0.0152	CbGeAlD
Epirubicin—ABCC1—parotid gland—head and neck cancer	0.000401	0.0149	CbGeAlD
Epirubicin—TOP2A—thyroid gland—head and neck cancer	0.000389	0.0144	CbGeAlD
Epirubicin—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.000372	0.171	CbGdCrCtD
Epirubicin—DHCR7—lymph node—head and neck cancer	0.000372	0.0138	CbGeAlD
Epirubicin—YWHAG—lymph node—head and neck cancer	0.000341	0.0127	CbGeAlD
Epirubicin—ABCC1—trachea—head and neck cancer	0.000296	0.011	CbGeAlD
Epirubicin—PLA2G4A—lymph node—head and neck cancer	0.000254	0.00945	CbGeAlD
Epirubicin—TOP2A—lymph node—head and neck cancer	0.000242	0.00898	CbGeAlD
Epirubicin—ABCC1—thyroid gland—head and neck cancer	0.000234	0.0087	CbGeAlD
Epirubicin—Neuropathy—Docetaxel—head and neck cancer	0.000155	0.00135	CcSEcCtD
Epirubicin—Alopecia—Vinblastine—head and neck cancer	0.000155	0.00135	CcSEcCtD
Epirubicin—Dry skin—Fluorouracil—head and neck cancer	0.000152	0.00132	CcSEcCtD
Epirubicin—Oesophagitis—Docetaxel—head and neck cancer	0.000151	0.00131	CcSEcCtD
Epirubicin—Neoplasm—Docetaxel—head and neck cancer	0.000149	0.0013	CcSEcCtD
Epirubicin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000148	0.00129	CcSEcCtD
Epirubicin—Pulmonary oedema—Docetaxel—head and neck cancer	0.000147	0.00128	CcSEcCtD
Epirubicin—Muscular weakness—Fluorouracil—head and neck cancer	0.000146	0.00127	CcSEcCtD
Epirubicin—ABCC1—lymph node—head and neck cancer	0.000145	0.0054	CbGeAlD
Epirubicin—Angiopathy—Hydroxyurea—head and neck cancer	0.000145	0.00126	CcSEcCtD
Epirubicin—Dysphagia—Fluorouracil—head and neck cancer	0.000143	0.00125	CcSEcCtD
Epirubicin—Sepsis—Docetaxel—head and neck cancer	0.000143	0.00125	CcSEcCtD
Epirubicin—Chills—Hydroxyurea—head and neck cancer	0.000143	0.00125	CcSEcCtD
Epirubicin—Eosinophilia—Fluorouracil—head and neck cancer	0.000142	0.00124	CcSEcCtD
Epirubicin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000141	0.00123	CcSEcCtD
Epirubicin—Alopecia—Hydroxyurea—head and neck cancer	0.000141	0.00123	CcSEcCtD
Epirubicin—Anaemia—Vinblastine—head and neck cancer	0.000141	0.00123	CcSEcCtD
Epirubicin—Angina pectoris—Fluorouracil—head and neck cancer	0.00014	0.00122	CcSEcCtD
Epirubicin—Phlebitis—Docetaxel—head and neck cancer	0.000139	0.00121	CcSEcCtD
Epirubicin—Erythema—Hydroxyurea—head and neck cancer	0.000139	0.00121	CcSEcCtD
Epirubicin—Thrombophlebitis—Docetaxel—head and neck cancer	0.000138	0.0012	CcSEcCtD
Epirubicin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000138	0.0012	CcSEcCtD
Epirubicin—Malaise—Vinblastine—head and neck cancer	0.000137	0.0012	CcSEcCtD
Epirubicin—Vertigo—Vinblastine—head and neck cancer	0.000137	0.00119	CcSEcCtD
Epirubicin—Leukopenia—Vinblastine—head and neck cancer	0.000136	0.00119	CcSEcCtD
Epirubicin—Pancytopenia—Fluorouracil—head and neck cancer	0.000136	0.00119	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000133	0.00116	CcSEcCtD
Epirubicin—Hepatic failure—Docetaxel—head and neck cancer	0.000133	0.00116	CcSEcCtD
Epirubicin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000132	0.00115	CcSEcCtD
Epirubicin—Convulsion—Vinblastine—head and neck cancer	0.000132	0.00115	CcSEcCtD
Epirubicin—Hypertension—Vinblastine—head and neck cancer	0.000131	0.00114	CcSEcCtD
Epirubicin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000131	0.00114	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—CASP8—head and neck cancer	0.00013	0.00273	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000129	0.00271	CbGpPWpGaD
Epirubicin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000129	0.00112	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—CDH1—head and neck cancer	0.000129	0.00269	CbGpPWpGaD
Epirubicin—Pneumonia—Fluorouracil—head and neck cancer	0.000129	0.00112	CcSEcCtD
Epirubicin—Anaemia—Hydroxyurea—head and neck cancer	0.000128	0.00112	CcSEcCtD
Epirubicin—Discomfort—Vinblastine—head and neck cancer	0.000128	0.00112	CcSEcCtD
Epirubicin—Hot flush—Docetaxel—head and neck cancer	0.000128	0.00111	CcSEcCtD
Epirubicin—Infestation NOS—Fluorouracil—head and neck cancer	0.000128	0.00111	CcSEcCtD
Epirubicin—Infestation—Fluorouracil—head and neck cancer	0.000128	0.00111	CcSEcCtD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000127	0.00266	CbGpPWpGaD
Epirubicin—Menopausal symptoms—Docetaxel—head and neck cancer	0.000127	0.00111	CcSEcCtD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000126	0.00264	CbGpPWpGaD
Epirubicin—Renal impairment—Docetaxel—head and neck cancer	0.000126	0.0011	CcSEcCtD
Epirubicin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000125	0.00109	CcSEcCtD
Epirubicin—Dermatitis bullous—Docetaxel—head and neck cancer	0.000125	0.00109	CcSEcCtD
Epirubicin—Malaise—Hydroxyurea—head and neck cancer	0.000125	0.00109	CcSEcCtD
Epirubicin—PLA2G4A—PLC beta mediated events—MAPK1—head and neck cancer	0.000125	0.00261	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000125	0.00261	CbGpPWpGaD
Epirubicin—Stomatitis—Fluorouracil—head and neck cancer	0.000125	0.00109	CcSEcCtD
Epirubicin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000124	0.00108	CcSEcCtD
Epirubicin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000124	0.00108	CcSEcCtD
Epirubicin—Leukopenia—Hydroxyurea—head and neck cancer	0.000124	0.00108	CcSEcCtD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—head and neck cancer	0.000123	0.00258	CbGpPWpGaD
Epirubicin—PLA2G4A—G-protein mediated events—MAPK1—head and neck cancer	0.000123	0.00257	CbGpPWpGaD
Epirubicin—Cardiac failure—Docetaxel—head and neck cancer	0.000123	0.00107	CcSEcCtD
Epirubicin—Lethargy—Docetaxel—head and neck cancer	0.000122	0.00106	CcSEcCtD
Epirubicin—UGT2B7—NRF2 pathway—GSTM1—head and neck cancer	0.000122	0.00256	CbGpPWpGaD
Epirubicin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000122	0.00106	CcSEcCtD
Epirubicin—Epistaxis—Fluorouracil—head and neck cancer	0.000121	0.00105	CcSEcCtD
Epirubicin—Convulsion—Hydroxyurea—head and neck cancer	0.00012	0.00105	CcSEcCtD
Epirubicin—Hyponatraemia—Docetaxel—head and neck cancer	0.00012	0.00105	CcSEcCtD
Epirubicin—Sinusitis—Fluorouracil—head and neck cancer	0.00012	0.00104	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00012	0.00104	CcSEcCtD
Epirubicin—Pain in extremity—Docetaxel—head and neck cancer	0.00012	0.00104	CcSEcCtD
Epirubicin—YWHAG—mTOR signaling pathway—HRAS—head and neck cancer	0.00012	0.00251	CbGpPWpGaD
Epirubicin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000119	0.00104	CcSEcCtD
Epirubicin—Anorexia—Vinblastine—head and neck cancer	0.000118	0.00103	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—PTEN—head and neck cancer	0.000118	0.00247	CbGpPWpGaD
Epirubicin—Migraine—Docetaxel—head and neck cancer	0.000118	0.00103	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000117	0.00102	CcSEcCtD
Epirubicin—Discomfort—Hydroxyurea—head and neck cancer	0.000117	0.00102	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—RAD51—head and neck cancer	0.000116	0.00243	CbGpPWpGaD
Epirubicin—Haemoglobin—Fluorouracil—head and neck cancer	0.000115	0.001	CcSEcCtD
Epirubicin—Rhinitis—Fluorouracil—head and neck cancer	0.000115	0.001	CcSEcCtD
Epirubicin—Haemorrhage—Fluorouracil—head and neck cancer	0.000115	0.001	CcSEcCtD
Epirubicin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000114	0.000995	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000114	0.00239	CbGpPWpGaD
Epirubicin—Pharyngitis—Fluorouracil—head and neck cancer	0.000114	0.000992	CcSEcCtD
Epirubicin—Oedema—Hydroxyurea—head and neck cancer	0.000113	0.000987	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000113	0.00237	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—STAT3—head and neck cancer	0.000113	0.00237	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000113	0.00236	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000113	0.00236	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000113	0.00236	CbGpPWpGaD
Epirubicin—Ataxia—Docetaxel—head and neck cancer	0.000113	0.000981	CcSEcCtD
Epirubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—AKT1—head and neck cancer	0.000113	0.00236	CbGpPWpGaD
Epirubicin—Infection—Hydroxyurea—head and neck cancer	0.000113	0.00098	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—BCL2—head and neck cancer	0.000112	0.00234	CbGpPWpGaD
Epirubicin—Paraesthesia—Vinblastine—head and neck cancer	0.000112	0.000972	CcSEcCtD
Epirubicin—Dehydration—Docetaxel—head and neck cancer	0.000111	0.00097	CcSEcCtD
Epirubicin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000111	0.000968	CcSEcCtD
Epirubicin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000111	0.000966	CcSEcCtD
Epirubicin—Liver function test abnormal—Docetaxel—head and neck cancer	0.000111	0.000963	CcSEcCtD
Epirubicin—PLA2G4A—PDGF Pathway—HRAS—head and neck cancer	0.00011	0.00231	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PTEN—head and neck cancer	0.00011	0.0023	CbGpPWpGaD
Epirubicin—Skin disorder—Hydroxyurea—head and neck cancer	0.00011	0.000958	CcSEcCtD
Epirubicin—Dry skin—Docetaxel—head and neck cancer	0.00011	0.000956	CcSEcCtD
Epirubicin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000109	0.000953	CcSEcCtD
Epirubicin—Abdominal pain upper—Docetaxel—head and neck cancer	0.000109	0.000953	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—TYMS—head and neck cancer	0.000108	0.00227	CbGpPWpGaD
Epirubicin—Breast disorder—Docetaxel—head and neck cancer	0.000108	0.000942	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—MAPK3—head and neck cancer	0.000108	0.00226	CbGpPWpGaD
Epirubicin—Anorexia—Hydroxyurea—head and neck cancer	0.000108	0.000941	CcSEcCtD
Epirubicin—Decreased appetite—Vinblastine—head and neck cancer	0.000108	0.000941	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000108	0.000939	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000108	0.000939	CcSEcCtD
Epirubicin—DHCR7—Metabolism—NAT2—head and neck cancer	0.000107	0.00225	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GSTM1—head and neck cancer	0.000107	0.00224	CbGpPWpGaD
Epirubicin—Nasopharyngitis—Docetaxel—head and neck cancer	0.000107	0.000933	CcSEcCtD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000107	0.00223	CbGpPWpGaD
Epirubicin—Pain—Vinblastine—head and neck cancer	0.000106	0.000925	CcSEcCtD
Epirubicin—Constipation—Vinblastine—head and neck cancer	0.000106	0.000925	CcSEcCtD
Epirubicin—YWHAG—mTOR signaling pathway—AKT1—head and neck cancer	0.000106	0.00221	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000106	0.00221	CbGpPWpGaD
Epirubicin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000106	0.00092	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—STAT3—head and neck cancer	0.000106	0.00221	CbGpPWpGaD
Epirubicin—Dysphagia—Docetaxel—head and neck cancer	0.000104	0.000901	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—TYMS—head and neck cancer	0.000103	0.00216	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—MAPK1—head and neck cancer	0.000103	0.00215	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—EGFR—head and neck cancer	0.000103	0.00215	CbGpPWpGaD
Epirubicin—Arrhythmia—Fluorouracil—head and neck cancer	0.000103	0.000893	CcSEcCtD
Epirubicin—Feeling abnormal—Vinblastine—head and neck cancer	0.000102	0.000892	CcSEcCtD
Epirubicin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000102	0.000885	CcSEcCtD
Epirubicin—UGT2B7—Biological oxidations—CYP1A1—head and neck cancer	0.000102	0.00212	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000101	0.00212	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000101	0.00212	CbGpPWpGaD
Epirubicin—Alopecia—Fluorouracil—head and neck cancer	0.000101	0.000883	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CCNA1—head and neck cancer	0.000101	0.00212	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK3—head and neck cancer	0.000101	0.00212	CbGpPWpGaD
Epirubicin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000101	0.00088	CcSEcCtD
Epirubicin—Angina pectoris—Docetaxel—head and neck cancer	0.000101	0.000878	CcSEcCtD
Epirubicin—Somnolence—Hydroxyurea—head and neck cancer	0.000101	0.000877	CcSEcCtD
Epirubicin—UGT2B7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.0001	0.0021	CbGpPWpGaD
Epirubicin—Erythema—Fluorouracil—head and neck cancer	9.99e-05	0.00087	CcSEcCtD
Epirubicin—Dyspepsia—Hydroxyurea—head and neck cancer	9.97e-05	0.000869	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—STAT3—head and neck cancer	9.94e-05	0.00208	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—MAPK3—head and neck cancer	9.86e-05	0.00206	CbGpPWpGaD
Epirubicin—Decreased appetite—Hydroxyurea—head and neck cancer	9.85e-05	0.000858	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—head and neck cancer	9.84e-05	0.00206	CbGpPWpGaD
Epirubicin—Pancytopenia—Docetaxel—head and neck cancer	9.83e-05	0.000856	CcSEcCtD
Epirubicin—Abdominal pain—Vinblastine—head and neck cancer	9.82e-05	0.000855	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	9.78e-05	0.000852	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	9.77e-05	0.00204	CbGpPWpGaD
Epirubicin—Fatigue—Hydroxyurea—head and neck cancer	9.77e-05	0.000851	CcSEcCtD
Epirubicin—Constipation—Hydroxyurea—head and neck cancer	9.69e-05	0.000844	CcSEcCtD
Epirubicin—Pain—Hydroxyurea—head and neck cancer	9.69e-05	0.000844	CcSEcCtD
Epirubicin—Neutropenia—Docetaxel—head and neck cancer	9.68e-05	0.000843	CcSEcCtD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK1—head and neck cancer	9.62e-05	0.00201	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—MAPK1—head and neck cancer	9.59e-05	0.00201	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—head and neck cancer	9.59e-05	0.00201	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MAPK3—head and neck cancer	9.5e-05	0.00199	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—DPYD—head and neck cancer	9.42e-05	0.00197	CbGpPWpGaD
Epirubicin—Weight increased—Docetaxel—head and neck cancer	9.42e-05	0.00082	CcSEcCtD
Epirubicin—Vision blurred—Fluorouracil—head and neck cancer	9.42e-05	0.00082	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MAPK3—head and neck cancer	9.4e-05	0.00197	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—MAPK1—head and neck cancer	9.38e-05	0.00196	CbGpPWpGaD
Epirubicin—Weight decreased—Docetaxel—head and neck cancer	9.36e-05	0.000816	CcSEcCtD
Epirubicin—Feeling abnormal—Hydroxyurea—head and neck cancer	9.34e-05	0.000813	CcSEcCtD
Epirubicin—Pneumonia—Docetaxel—head and neck cancer	9.28e-05	0.000808	CcSEcCtD
Epirubicin—Anaemia—Fluorouracil—head and neck cancer	9.24e-05	0.000804	CcSEcCtD
Epirubicin—Infestation—Docetaxel—head and neck cancer	9.23e-05	0.000804	CcSEcCtD
Epirubicin—Infestation NOS—Docetaxel—head and neck cancer	9.23e-05	0.000804	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—TYMS—head and neck cancer	9.21e-05	0.00193	CbGpPWpGaD
Epirubicin—Hypersensitivity—Vinblastine—head and neck cancer	9.15e-05	0.000797	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	9.15e-05	0.000797	CcSEcCtD
Epirubicin—Renal failure—Docetaxel—head and neck cancer	9.07e-05	0.00079	CcSEcCtD
Epirubicin—Neuropathy peripheral—Docetaxel—head and neck cancer	9.05e-05	0.000788	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MAPK1—head and neck cancer	9.04e-05	0.00189	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—EGFR—head and neck cancer	9.03e-05	0.00189	CbGpPWpGaD
Epirubicin—Jaundice—Docetaxel—head and neck cancer	9e-05	0.000783	CcSEcCtD
Epirubicin—Stomatitis—Docetaxel—head and neck cancer	9e-05	0.000783	CcSEcCtD
Epirubicin—Conjunctivitis—Docetaxel—head and neck cancer	8.97e-05	0.000781	CcSEcCtD
Epirubicin—Body temperature increased—Hydroxyurea—head and neck cancer	8.96e-05	0.00078	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MAPK1—head and neck cancer	8.95e-05	0.00187	CbGpPWpGaD
Epirubicin—Leukopenia—Fluorouracil—head and neck cancer	8.94e-05	0.000779	CcSEcCtD
Epirubicin—DHCR7—Metabolism—YAP1—head and neck cancer	8.94e-05	0.00187	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—UROD—head and neck cancer	8.93e-05	0.00187	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—PIK3CA—head and neck cancer	8.93e-05	0.00187	CbGpPWpGaD
Epirubicin—Asthenia—Vinblastine—head and neck cancer	8.91e-05	0.000776	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—head and neck cancer	8.84e-05	0.00185	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—UROD—head and neck cancer	8.76e-05	0.00183	CbGpPWpGaD
Epirubicin—Hepatobiliary disease—Docetaxel—head and neck cancer	8.73e-05	0.00076	CcSEcCtD
Epirubicin—Epistaxis—Docetaxel—head and neck cancer	8.7e-05	0.000758	CcSEcCtD
Epirubicin—Convulsion—Fluorouracil—head and neck cancer	8.66e-05	0.000754	CcSEcCtD
Epirubicin—Agranulocytosis—Docetaxel—head and neck cancer	8.61e-05	0.00075	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—head and neck cancer	8.52e-05	0.00178	CbGpPWpGaD
Epirubicin—Myalgia—Fluorouracil—head and neck cancer	8.51e-05	0.000741	CcSEcCtD
Epirubicin—Chest pain—Fluorouracil—head and neck cancer	8.51e-05	0.000741	CcSEcCtD
Epirubicin—Diarrhoea—Vinblastine—head and neck cancer	8.5e-05	0.00074	CcSEcCtD
Epirubicin—Discomfort—Fluorouracil—head and neck cancer	8.4e-05	0.000732	CcSEcCtD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—head and neck cancer	8.35e-05	0.00175	CbGpPWpGaD
Epirubicin—Hypersensitivity—Hydroxyurea—head and neck cancer	8.35e-05	0.000727	CcSEcCtD
Epirubicin—Haemoglobin—Docetaxel—head and neck cancer	8.33e-05	0.000725	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	8.33e-05	0.00174	CbGpPWpGaD
Epirubicin—Rhinitis—Docetaxel—head and neck cancer	8.31e-05	0.000723	CcSEcCtD
Epirubicin—Haemorrhage—Docetaxel—head and neck cancer	8.28e-05	0.000722	CcSEcCtD
Epirubicin—Hepatitis—Docetaxel—head and neck cancer	8.28e-05	0.000722	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—HRAS—head and neck cancer	8.26e-05	0.00173	CbGpPWpGaD
Epirubicin—Hypoaesthesia—Docetaxel—head and neck cancer	8.24e-05	0.000718	CcSEcCtD
Epirubicin—Confusional state—Fluorouracil—head and neck cancer	8.22e-05	0.000716	CcSEcCtD
Epirubicin—Pharyngitis—Docetaxel—head and neck cancer	8.22e-05	0.000716	CcSEcCtD
Epirubicin—Dizziness—Vinblastine—head and neck cancer	8.22e-05	0.000715	CcSEcCtD
Epirubicin—Urinary tract disorder—Docetaxel—head and neck cancer	8.18e-05	0.000713	CcSEcCtD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	8.16e-05	0.00171	CbGpPWpGaD
Epirubicin—Oedema peripheral—Docetaxel—head and neck cancer	8.16e-05	0.000711	CcSEcCtD
Epirubicin—Anaphylactic shock—Fluorouracil—head and neck cancer	8.15e-05	0.00071	CcSEcCtD
Epirubicin—Oedema—Fluorouracil—head and neck cancer	8.15e-05	0.00071	CcSEcCtD
Epirubicin—Connective tissue disorder—Docetaxel—head and neck cancer	8.14e-05	0.000709	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—RAD51—head and neck cancer	8.13e-05	0.0017	CbGpPWpGaD
Epirubicin—Asthenia—Hydroxyurea—head and neck cancer	8.13e-05	0.000708	CcSEcCtD
Epirubicin—Urethral disorder—Docetaxel—head and neck cancer	8.12e-05	0.000707	CcSEcCtD
Epirubicin—Infection—Fluorouracil—head and neck cancer	8.1e-05	0.000706	CcSEcCtD
Epirubicin—Nervous system disorder—Fluorouracil—head and neck cancer	8e-05	0.000696	CcSEcCtD
Epirubicin—Thrombocytopenia—Fluorouracil—head and neck cancer	7.98e-05	0.000695	CcSEcCtD
Epirubicin—Visual impairment—Docetaxel—head and neck cancer	7.98e-05	0.000695	CcSEcCtD
Epirubicin—Tachycardia—Fluorouracil—head and neck cancer	7.96e-05	0.000693	CcSEcCtD
Epirubicin—Vomiting—Vinblastine—head and neck cancer	7.9e-05	0.000688	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.85e-05	0.00164	CbGpPWpGaD
Epirubicin—Erythema multiforme—Docetaxel—head and neck cancer	7.83e-05	0.000682	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—TYMS—head and neck cancer	7.81e-05	0.00163	CbGpPWpGaD
Epirubicin—Headache—Vinblastine—head and neck cancer	7.78e-05	0.000678	CcSEcCtD
Epirubicin—Anorexia—Fluorouracil—head and neck cancer	7.77e-05	0.000677	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PIK3CA—head and neck cancer	7.76e-05	0.00162	CbGpPWpGaD
Epirubicin—Diarrhoea—Hydroxyurea—head and neck cancer	7.75e-05	0.000675	CcSEcCtD
Epirubicin—Eye disorder—Docetaxel—head and neck cancer	7.74e-05	0.000674	CcSEcCtD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—head and neck cancer	7.73e-05	0.00162	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	7.71e-05	0.00161	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—head and neck cancer	7.7e-05	0.00161	CbGpPWpGaD
Epirubicin—Cardiac disorder—Docetaxel—head and neck cancer	7.69e-05	0.00067	CcSEcCtD
Epirubicin—Flushing—Docetaxel—head and neck cancer	7.69e-05	0.00067	CcSEcCtD
Epirubicin—PLA2G4A—Opioid Signalling—MAPK1—head and neck cancer	7.67e-05	0.0016	CbGpPWpGaD
Epirubicin—Hypotension—Fluorouracil—head and neck cancer	7.62e-05	0.000664	CcSEcCtD
Epirubicin—PLA2G4A—Endothelins—HRAS—head and neck cancer	7.53e-05	0.00158	CbGpPWpGaD
Epirubicin—Angiopathy—Docetaxel—head and neck cancer	7.52e-05	0.000655	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—head and neck cancer	7.5e-05	0.00157	CbGpPWpGaD
Epirubicin—Dizziness—Hydroxyurea—head and neck cancer	7.49e-05	0.000652	CcSEcCtD
Epirubicin—Immune system disorder—Docetaxel—head and neck cancer	7.48e-05	0.000652	CcSEcCtD
Epirubicin—Mediastinal disorder—Docetaxel—head and neck cancer	7.47e-05	0.00065	CcSEcCtD
Epirubicin—Chills—Docetaxel—head and neck cancer	7.43e-05	0.000647	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	7.43e-05	0.000647	CcSEcCtD
Epirubicin—Arrhythmia—Docetaxel—head and neck cancer	7.4e-05	0.000645	CcSEcCtD
Epirubicin—Nausea—Vinblastine—head and neck cancer	7.38e-05	0.000643	CcSEcCtD
Epirubicin—Insomnia—Fluorouracil—head and neck cancer	7.38e-05	0.000642	CcSEcCtD
Epirubicin—Paraesthesia—Fluorouracil—head and neck cancer	7.32e-05	0.000638	CcSEcCtD
Epirubicin—Alopecia—Docetaxel—head and neck cancer	7.32e-05	0.000638	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—AKT1—head and neck cancer	7.29e-05	0.00153	CbGpPWpGaD
Epirubicin—Dyspnoea—Fluorouracil—head and neck cancer	7.27e-05	0.000633	CcSEcCtD
Epirubicin—Mental disorder—Docetaxel—head and neck cancer	7.26e-05	0.000632	CcSEcCtD
Epirubicin—Somnolence—Fluorouracil—head and neck cancer	7.25e-05	0.000631	CcSEcCtD
Epirubicin—Erythema—Docetaxel—head and neck cancer	7.21e-05	0.000628	CcSEcCtD
Epirubicin—Malnutrition—Docetaxel—head and neck cancer	7.21e-05	0.000628	CcSEcCtD
Epirubicin—Vomiting—Hydroxyurea—head and neck cancer	7.2e-05	0.000627	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	7.19e-05	0.00151	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—head and neck cancer	7.18e-05	0.0015	CbGpPWpGaD
Epirubicin—Dyspepsia—Fluorouracil—head and neck cancer	7.18e-05	0.000625	CcSEcCtD
Epirubicin—Rash—Hydroxyurea—head and neck cancer	7.14e-05	0.000622	CcSEcCtD
Epirubicin—Dermatitis—Hydroxyurea—head and neck cancer	7.14e-05	0.000622	CcSEcCtD
Epirubicin—Headache—Hydroxyurea—head and neck cancer	7.1e-05	0.000618	CcSEcCtD
Epirubicin—Decreased appetite—Fluorouracil—head and neck cancer	7.09e-05	0.000617	CcSEcCtD
Epirubicin—Dysgeusia—Docetaxel—head and neck cancer	7.06e-05	0.000615	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	7.04e-05	0.000613	CcSEcCtD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	7.02e-05	0.00147	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—UROD—head and neck cancer	7e-05	0.00146	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TYMS—head and neck cancer	6.98e-05	0.00146	CbGpPWpGaD
Epirubicin—Back pain—Docetaxel—head and neck cancer	6.98e-05	0.000608	CcSEcCtD
Epirubicin—Pain—Fluorouracil—head and neck cancer	6.97e-05	0.000607	CcSEcCtD
Epirubicin—Muscle spasms—Docetaxel—head and neck cancer	6.93e-05	0.000604	CcSEcCtD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—head and neck cancer	6.82e-05	0.00143	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	6.8e-05	0.00142	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.8e-05	0.00142	CbGpPWpGaD
Epirubicin—Nausea—Hydroxyurea—head and neck cancer	6.73e-05	0.000586	CcSEcCtD
Epirubicin—Feeling abnormal—Fluorouracil—head and neck cancer	6.72e-05	0.000585	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.72e-05	0.00141	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.68e-05	0.0014	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PTEN—head and neck cancer	6.67e-05	0.0014	CbGpPWpGaD
Epirubicin—Anaemia—Docetaxel—head and neck cancer	6.67e-05	0.000581	CcSEcCtD
Epirubicin—PLA2G4A—Endothelins—AKT1—head and neck cancer	6.65e-05	0.00139	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.62e-05	0.00138	CbGpPWpGaD
Epirubicin—Urticaria—Fluorouracil—head and neck cancer	6.48e-05	0.000564	CcSEcCtD
Epirubicin—Syncope—Docetaxel—head and neck cancer	6.47e-05	0.000563	CcSEcCtD
Epirubicin—Leukopenia—Docetaxel—head and neck cancer	6.46e-05	0.000562	CcSEcCtD
Epirubicin—Body temperature increased—Fluorouracil—head and neck cancer	6.45e-05	0.000561	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—AKT1—head and neck cancer	6.4e-05	0.00134	CbGpPWpGaD
Epirubicin—Palpitations—Docetaxel—head and neck cancer	6.37e-05	0.000555	CcSEcCtD
Epirubicin—Loss of consciousness—Docetaxel—head and neck cancer	6.34e-05	0.000552	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—TP53—head and neck cancer	6.32e-05	0.00132	CbGpPWpGaD
Epirubicin—Cough—Docetaxel—head and neck cancer	6.29e-05	0.000548	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.29e-05	0.00132	CbGpPWpGaD
Epirubicin—Convulsion—Docetaxel—head and neck cancer	6.25e-05	0.000544	CcSEcCtD
Epirubicin—Hypertension—Docetaxel—head and neck cancer	6.23e-05	0.000542	CcSEcCtD
Epirubicin—PLA2G4A—Phospholipid metabolism—PTEN—head and neck cancer	6.16e-05	0.00129	CbGpPWpGaD
Epirubicin—Arthralgia—Docetaxel—head and neck cancer	6.14e-05	0.000535	CcSEcCtD
Epirubicin—Chest pain—Docetaxel—head and neck cancer	6.14e-05	0.000535	CcSEcCtD
Epirubicin—Myalgia—Docetaxel—head and neck cancer	6.14e-05	0.000535	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	6.1e-05	0.000531	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—KISS1—head and neck cancer	6.06e-05	0.00127	CbGpPWpGaD
Epirubicin—Hypersensitivity—Fluorouracil—head and neck cancer	6.01e-05	0.000523	CcSEcCtD
Epirubicin—Dry mouth—Docetaxel—head and neck cancer	6e-05	0.000523	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—head and neck cancer	5.96e-05	0.00125	CbGpPWpGaD
Epirubicin—Confusional state—Docetaxel—head and neck cancer	5.93e-05	0.000517	CcSEcCtD
Epirubicin—Anaphylactic shock—Docetaxel—head and neck cancer	5.89e-05	0.000513	CcSEcCtD
Epirubicin—Oedema—Docetaxel—head and neck cancer	5.89e-05	0.000513	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.86e-05	0.00123	CbGpPWpGaD
Epirubicin—Infection—Docetaxel—head and neck cancer	5.85e-05	0.000509	CcSEcCtD
Epirubicin—Shock—Docetaxel—head and neck cancer	5.79e-05	0.000504	CcSEcCtD
Epirubicin—Nervous system disorder—Docetaxel—head and neck cancer	5.77e-05	0.000503	CcSEcCtD
Epirubicin—Pruritus—Fluorouracil—head and neck cancer	5.77e-05	0.000502	CcSEcCtD
Epirubicin—Thrombocytopenia—Docetaxel—head and neck cancer	5.76e-05	0.000502	CcSEcCtD
Epirubicin—Tachycardia—Docetaxel—head and neck cancer	5.74e-05	0.0005	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.73e-05	0.0012	CbGpPWpGaD
Epirubicin—Skin disorder—Docetaxel—head and neck cancer	5.72e-05	0.000498	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MAPK3—head and neck cancer	5.7e-05	0.00119	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.68e-05	0.00119	CbGpPWpGaD
Epirubicin—Anorexia—Docetaxel—head and neck cancer	5.61e-05	0.000489	CcSEcCtD
Epirubicin—Diarrhoea—Fluorouracil—head and neck cancer	5.58e-05	0.000486	CcSEcCtD
Epirubicin—Hypotension—Docetaxel—head and neck cancer	5.5e-05	0.000479	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.48e-05	0.00115	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—TYMS—head and neck cancer	5.46e-05	0.00114	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5.45e-05	0.00114	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.43e-05	0.00114	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—head and neck cancer	5.42e-05	0.00113	CbGpPWpGaD
Epirubicin—Dizziness—Fluorouracil—head and neck cancer	5.39e-05	0.00047	CcSEcCtD
Epirubicin—DHCR7—Metabolism—TYMS—head and neck cancer	5.37e-05	0.00112	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	5.36e-05	0.000467	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—AKT1—head and neck cancer	5.34e-05	0.00112	CbGpPWpGaD
Epirubicin—Insomnia—Docetaxel—head and neck cancer	5.32e-05	0.000464	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GSTM1—head and neck cancer	5.31e-05	0.00111	CbGpPWpGaD
Epirubicin—Paraesthesia—Docetaxel—head and neck cancer	5.29e-05	0.00046	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—PTEN—head and neck cancer	5.26e-05	0.0011	CbGpPWpGaD
Epirubicin—Dyspnoea—Docetaxel—head and neck cancer	5.25e-05	0.000457	CcSEcCtD
Epirubicin—Somnolence—Docetaxel—head and neck cancer	5.23e-05	0.000456	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCND1—head and neck cancer	5.19e-05	0.00109	CbGpPWpGaD
Epirubicin—Vomiting—Fluorouracil—head and neck cancer	5.18e-05	0.000452	CcSEcCtD
Epirubicin—Dyspepsia—Docetaxel—head and neck cancer	5.18e-05	0.000451	CcSEcCtD
Epirubicin—Rash—Fluorouracil—head and neck cancer	5.14e-05	0.000448	CcSEcCtD
Epirubicin—Dermatitis—Fluorouracil—head and neck cancer	5.14e-05	0.000447	CcSEcCtD
Epirubicin—Decreased appetite—Docetaxel—head and neck cancer	5.12e-05	0.000446	CcSEcCtD
Epirubicin—Headache—Fluorouracil—head and neck cancer	5.11e-05	0.000445	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GPX1—head and neck cancer	5.08e-05	0.00106	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Docetaxel—head and neck cancer	5.08e-05	0.000443	CcSEcCtD
Epirubicin—Fatigue—Docetaxel—head and neck cancer	5.07e-05	0.000442	CcSEcCtD
Epirubicin—Constipation—Docetaxel—head and neck cancer	5.03e-05	0.000438	CcSEcCtD
Epirubicin—Pain—Docetaxel—head and neck cancer	5.03e-05	0.000438	CcSEcCtD
Epirubicin—DHCR7—Metabolism—CYP1A1—head and neck cancer	5.03e-05	0.00105	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GRP—head and neck cancer	4.99e-05	0.00104	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.95e-05	0.00104	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.92e-05	0.00103	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TYMS—head and neck cancer	4.88e-05	0.00102	CbGpPWpGaD
Epirubicin—Feeling abnormal—Docetaxel—head and neck cancer	4.85e-05	0.000422	CcSEcCtD
Epirubicin—Nausea—Fluorouracil—head and neck cancer	4.84e-05	0.000422	CcSEcCtD
Epirubicin—Gastrointestinal pain—Docetaxel—head and neck cancer	4.81e-05	0.000419	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.75e-05	0.000994	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—head and neck cancer	4.7e-05	0.000984	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.68e-05	0.00098	CbGpPWpGaD
Epirubicin—Body temperature increased—Docetaxel—head and neck cancer	4.65e-05	0.000405	CcSEcCtD
Epirubicin—Abdominal pain—Docetaxel—head and neck cancer	4.65e-05	0.000405	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CCND1—head and neck cancer	4.64e-05	0.000971	CbGpPWpGaD
Epirubicin—YWHAG—Membrane Trafficking—AKT1—head and neck cancer	4.54e-05	0.000949	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	4.49e-05	0.00094	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.46e-05	0.000933	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.46e-05	0.000933	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—head and neck cancer	4.35e-05	0.000911	CbGpPWpGaD
Epirubicin—PLA2G4A—Phospholipid metabolism—PIK3CA—head and neck cancer	4.35e-05	0.000909	CbGpPWpGaD
Epirubicin—Hypersensitivity—Docetaxel—head and neck cancer	4.34e-05	0.000378	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.29e-05	0.000898	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MAPK3—head and neck cancer	4.28e-05	0.000895	CbGpPWpGaD
Epirubicin—Asthenia—Docetaxel—head and neck cancer	4.22e-05	0.000368	CcSEcCtD
Epirubicin—Pruritus—Docetaxel—head and neck cancer	4.16e-05	0.000363	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.13e-05	0.000865	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MAPK1—head and neck cancer	4.07e-05	0.000852	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.06e-05	0.000849	CbGpPWpGaD
Epirubicin—Diarrhoea—Docetaxel—head and neck cancer	4.03e-05	0.000351	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.93e-05	0.000823	CbGpPWpGaD
Epirubicin—Dizziness—Docetaxel—head and neck cancer	3.89e-05	0.000339	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.87e-05	0.000809	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.86e-05	0.000808	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.86e-05	0.000808	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.86e-05	0.000808	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MAPK3—head and neck cancer	3.83e-05	0.0008	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.82e-05	0.0008	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	3.82e-05	0.000799	CbGpPWpGaD
Epirubicin—Vomiting—Docetaxel—head and neck cancer	3.74e-05	0.000326	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.74e-05	0.000783	CbGpPWpGaD
Epirubicin—Rash—Docetaxel—head and neck cancer	3.71e-05	0.000323	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—NAT2—head and neck cancer	3.71e-05	0.000776	CbGpPWpGaD
Epirubicin—Dermatitis—Docetaxel—head and neck cancer	3.71e-05	0.000323	CcSEcCtD
Epirubicin—Headache—Docetaxel—head and neck cancer	3.69e-05	0.000321	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—MAPK1—head and neck cancer	3.64e-05	0.000762	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NAT2—head and neck cancer	3.64e-05	0.000761	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	3.61e-05	0.000756	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	3.59e-05	0.000752	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KISS1—head and neck cancer	3.58e-05	0.000748	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CCND1—head and neck cancer	3.52e-05	0.000736	CbGpPWpGaD
Epirubicin—Nausea—Docetaxel—head and neck cancer	3.5e-05	0.000304	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	3.44e-05	0.000719	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.35e-05	0.000701	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—DPYD—head and neck cancer	3.25e-05	0.000681	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MAPK3—head and neck cancer	3.24e-05	0.000678	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.24e-05	0.000678	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—DPYD—head and neck cancer	3.19e-05	0.000667	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.16e-05	0.000661	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.09e-05	0.000646	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—YAP1—head and neck cancer	3.09e-05	0.000646	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MAPK1—head and neck cancer	3.09e-05	0.000646	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—head and neck cancer	3.06e-05	0.000639	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.06e-05	0.000639	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—YAP1—head and neck cancer	3.03e-05	0.000633	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTGS2—head and neck cancer	2.99e-05	0.000626	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	2.98e-05	0.000624	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GRP—head and neck cancer	2.95e-05	0.000616	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NAT2—head and neck cancer	2.91e-05	0.000608	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MAPK3—head and neck cancer	2.9e-05	0.000607	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT6—head and neck cancer	2.86e-05	0.000598	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MAPK1—head and neck cancer	2.76e-05	0.000577	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	2.75e-05	0.000575	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.74e-05	0.000573	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTEN—head and neck cancer	2.61e-05	0.000546	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—DPYD—head and neck cancer	2.55e-05	0.000533	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—YAP1—head and neck cancer	2.53e-05	0.00053	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—head and neck cancer	2.46e-05	0.000514	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	2.44e-05	0.00051	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—YAP1—head and neck cancer	2.42e-05	0.000506	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—head and neck cancer	2.32e-05	0.000485	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—head and neck cancer	2.32e-05	0.000484	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.27e-05	0.000476	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.27e-05	0.000475	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.16e-05	0.000452	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK3—head and neck cancer	2.03e-05	0.000424	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.98e-05	0.000415	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—head and neck cancer	1.97e-05	0.000412	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK1—head and neck cancer	1.93e-05	0.000404	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK3—head and neck cancer	1.86e-05	0.000389	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TYMS—head and neck cancer	1.85e-05	0.000388	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—head and neck cancer	1.84e-05	0.000385	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—head and neck cancer	1.83e-05	0.000383	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TYMS—head and neck cancer	1.82e-05	0.00038	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.82e-05	0.00038	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—head and neck cancer	1.8e-05	0.000376	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK1—head and neck cancer	1.77e-05	0.000371	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX1—head and neck cancer	1.75e-05	0.000367	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1A1—head and neck cancer	1.74e-05	0.000363	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX1—head and neck cancer	1.72e-05	0.00036	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1A1—head and neck cancer	1.7e-05	0.000356	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—head and neck cancer	1.62e-05	0.000339	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.58e-05	0.000332	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—head and neck cancer	1.54e-05	0.000322	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—head and neck cancer	1.5e-05	0.000315	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—head and neck cancer	1.49e-05	0.000311	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TYMS—head and neck cancer	1.45e-05	0.000304	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—head and neck cancer	1.44e-05	0.0003	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—head and neck cancer	1.42e-05	0.000298	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.4e-05	0.000293	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX1—head and neck cancer	1.37e-05	0.000288	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.36e-05	0.000285	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—head and neck cancer	1.33e-05	0.000278	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOTCH1—head and neck cancer	1.3e-05	0.000272	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—head and neck cancer	1.26e-05	0.000263	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH1—head and neck cancer	1.14e-05	0.000239	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.12e-05	0.000234	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK3—head and neck cancer	1.07e-05	0.000224	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—head and neck cancer	1.03e-05	0.000216	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK1—head and neck cancer	1.02e-05	0.000213	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—head and neck cancer	1.02e-05	0.000213	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—head and neck cancer	1.01e-05	0.000212	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—head and neck cancer	9.66e-06	0.000202	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTEN—head and neck cancer	9.01e-06	0.000188	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTEN—head and neck cancer	8.83e-06	0.000185	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—head and neck cancer	8.82e-06	0.000185	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTEN—head and neck cancer	8.43e-06	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—head and neck cancer	8.16e-06	0.000171	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—head and neck cancer	8.09e-06	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—head and neck cancer	7.85e-06	0.000164	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—head and neck cancer	7.65e-06	0.00016	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—head and neck cancer	7.54e-06	0.000158	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTEN—head and neck cancer	7.39e-06	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—head and neck cancer	7.21e-06	0.000151	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK3—head and neck cancer	7.2e-06	0.000151	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTEN—head and neck cancer	7.06e-06	0.000148	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK1—head and neck cancer	6.85e-06	0.000143	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—head and neck cancer	6.85e-06	0.000143	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—head and neck cancer	6.67e-06	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—head and neck cancer	6.61e-06	0.000138	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—head and neck cancer	6.35e-06	0.000133	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK3—head and neck cancer	6.31e-06	0.000132	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—head and neck cancer	6.23e-06	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK1—head and neck cancer	6e-06	0.000126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—head and neck cancer	6e-06	0.000126	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—head and neck cancer	5.95e-06	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—head and neck cancer	5.5e-06	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—head and neck cancer	5.21e-06	0.000109	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—head and neck cancer	5.19e-06	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—head and neck cancer	5.09e-06	0.000107	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—head and neck cancer	5.04e-06	0.000105	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—head and neck cancer	4.98e-06	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—head and neck cancer	4.86e-06	0.000102	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—head and neck cancer	4.82e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—head and neck cancer	4.26e-06	8.91e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—head and neck cancer	4.07e-06	8.51e-05	CbGpPWpGaD
